Plantarc Bio Ltd Market Cap ($1.96 Million)
Market Cap & Net Worth: Plantarc Bio Ltd (PLNT)
Plantarc Bio Ltd market cap. Plantarc Bio Ltd (TA:PLNT) has a market capitalization of $1.96 Million (ILA731.02 Million) as of November 1, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30079 globally and #437 in its home market, demonstrating a 1.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Plantarc Bio Ltd's stock price ILA220.90 by its total outstanding shares 3309259 (3.31 Million). Also see PLNT cash flow conversion for how efficiently the company converts equity into cash flow.
Plantarc Bio Ltd Market Cap History (2021–2025)
Plantarc Bio Ltd market cap history from 2021 to 2025. Data shows change from $6.67 Million to $1.96 Million (-33.36% CAGR). Check PLNT share price today for real-time trading data and today's change.
Plantarc Bio Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Plantarc Bio Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Plantarc Bio Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.63x
Plantarc Bio Ltd's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $7.02 Million | $100.00K | -$4.98 Million | 70.24x | N/A |
| 2023 | $2.99 Million | $4.78 Million | -$2.11 Million | 0.63x | N/A |
| 2024 | $2.79 Million | $4.40 Million | -$2.57 Million | 0.63x | N/A |
Competitor Companies of PLNT by Market Capitalization
Companies near Plantarc Bio Ltd in the global market cap rankings as of November 1, 2026. Also see Plantarc Bio Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Plantarc Bio Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Plantarc Bio Ltd (2021–2025)
Market capitalization of Plantarc Bio Ltd from 2021 to today. Between 2021 and today, Plantarc Bio Ltd's market cap moved from $6.67 Million to $ 1.96 Million, with a yearly change of -33.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ILA1.96 Million | -29.69% |
| 2024 | ILA2.79 Million | -6.74% |
| 2023 | ILA2.99 Million | -57.45% |
| 2022 | ILA7.02 Million | +5.28% |
| 2021 | ILA6.67 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Plantarc Bio Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.96 Million USD |
| MoneyControl | $1.96 Million USD |
| MarketWatch | $1.96 Million USD |
| marketcap.company | $1.96 Million USD |
| Reuters | $1.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Plantarc Bio Ltd
PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.